TNF and breast cancer: Multiple studies have established an immune-modulatory role for miR-146b, including suppression of IL-6 allowing p16-dependent tumorigenesis in breast cancer [24], as well as suppression of multiple other pro-inflammatory cytokines and chemokines such as TNF-alpha, IL-8, and IL-10 [25].